Introduction
============

The classic T cell activation is regulated by two signal transduction pathways: one is antigen dependent, and the other is antigen independent. The antigen-independent signaling includes positive and negative second signals. PD-1 and CTLA-4 are two immune-inhibitory checkpoint molecules that suppress T cell-mediated immune responses, leading to the development of tumors.[@b1-ott-9-5023] Cancer immunoediting is a process that consists of immunosurveillance and tumor progression.[@b2-ott-9-5023] It has three phases: elimination, equilibrium, and escape. In elimination phase, tumor cells are recognized by upregulated tumor antigen expression and killed by different types of immune effector cells. In equilibrium phase, tumor cells change into variants and induce immunosuppression to avoid constant immune pressure, resulting in a state of functional dormancy of the tumor. In escape phase, various immunosuppressive molecules and cytokines are activated by the tumor cells and contribute to tumor outgrowth, causing clinically apparent disease. PD-L1 is a PD-1 ligand that plays an important role in the inhibition of T cell-mediated immune response. Binding of PD-L1 to PD-1 causes the exhaustion of effector T cells and immune escape of tumor cells, leading to poor prognosis. In rare cases, positive PD-L1 expression has been reported to be associated with better clinical outcome. Clinical trials have demonstrated that monoclonal antibodies (mAbs) that target PD-L1 or its receptor PD-1 prevent the inhibitory effects of PD-1/PD-L1 pathway and enhance T cell functions, leading to impressive outcomes in patients with melanoma, renal cell carcinoma (RCC), non-small-cell lung cancer (NSCLC), and bladder cancer.[@b3-ott-9-5023]--[@b5-ott-9-5023] However, the predictive effects of PD-L1 in response to PD-1/PD-L1 antibodies in some tumors are not conclusive, and the indication of PD-L1 expression in tumors remains controversial and needs to be understood profoundly. This review focuses on PD-L1 expression and its association with clinical outcomes in different cancers and factors affecting the accuracy of prediction of PD-L1. We also discuss the value of PD-L1 in predicting the clinical efficacy of PD-1/PD-L1 checkpoint blockades in cancer patients.

Expression and biological function of PD-L1
===========================================

PD-L1 is mainly expressed on the surface of tumor cells and antigen-presenting cells in various solid malignancies such as squamous cell carcinoma of the head and neck, melanoma, and carcinomas of the brain, thyroid, thymus, esophagus, lung, breast, gastrointestinal tract, colorectum, liver, pancreas, kidney, adrenal cortex, bladder, urothelium, ovary, and skin.[@b6-ott-9-5023]--[@b12-ott-9-5023] In tumor microenvironment, PD-L1 expression on tumor cells and other tumor-promoting cells is caused by two mechanisms, constitutive mechanism and induced mechanism, both of which depend on two binding sites of IRF-1.[@b13-ott-9-5023] For example, in BRAFV600-mutated melanoma, PD-L1 expression is a result of cancer cells' adaptive response to immune attack evoked by cytokines, or a constitutive expression which is a result of oncogenic processes.[@b14-ott-9-5023] PD-L1 is rarely expressed on normal tissues but inducibly expressed on tumor site, which makes PD-L1 pathway uniquely different from other coinhibitory pathways,[@b15-ott-9-5023] indicating that the selective expression of PD-L1 may have some association with clinical outcomes of the cancer patients and can be a selective target for antitumor therapy.

PD-1 (CD279), a PD-L1 receptor, is expressed on CD4^−^CD8^−^ thymocytes and CD4^+^CD8^+^ T cells during thymic development and is selectively expressed on CD4^+^ and CD8^+^ T cells, monocytes, natural killer T cells, B cells, and dendritic cells upon induction by TCR and cytokine arousal.[@b16-ott-9-5023],[@b17-ott-9-5023] In chronically infected mice model, high expression of PD-1 on T cells leads to T cell exhaustion and makes the exhausted CD8^+^ T cells lose effector function of secreting cytokines such as IL-2, IFN-γ, and TNF-α.[@b18-ott-9-5023] Binding of PD-L1 to PD-1 leads to the formation of PD-1/TCR inhibitory microcluster that recruits SHP1/2 molecule and dephosphorylates multiple members of TCR signaling pathway, leading to the shut-off of T cell activation through induction of apoptosis, reduction of proliferation, and inhibition of cytokine secretion ([Figure 1](#f1-ott-9-5023){ref-type="fig"}). However, whether all kinds of cancers utilize the same action mechanism of PD-L1 signaling, that is, whether different prognosis of different cancers is caused by different PD-L1 mechanisms, remains inconclusive and needs to be further explored.

PD-1/PD-L1 pathway plays a prominent role in immune regulation by delivering inhibitory signals to maintain the balance in T cell activation, tolerance, and immune-mediated tissue damage. It exerts significant inhibitory functions in persistent antigenic stimulation environment such as exposure to self-antigen, chronic viral infection, and tumor.[@b19-ott-9-5023]--[@b21-ott-9-5023] PD-L1 can also serve as a receptor transmitting antiapoptotic signal to tumor cells to protect them from apoptosis. Moreover, Shi et al[@b22-ott-9-5023] have demonstrated that PD-L1 may have oncogenic function during colon cancer carcinogenesis. PD-L1 not only inhibits T cell proliferation and cytokine production but also enhances T cell activation.[@b23-ott-9-5023] The explanation of this contradictory phenomenon is unknown.

In normal tissues, PD-1 signaling in T cells regulates immune responses to decrease damage to adjacent tissue, and counteracts the development of autoimmunity by promoting tolerance to self-antigens. PD-L1 receptor is also expressed on the surface of CD4^+^Foxp3^+^ regulatory T cells (Tregs), a subset of CD4^+^ T cells that play a critical role in maintaining immune tolerance and weakening immune responses, to promote the development, maintenance, and immunosuppressive function of Tregs through inhibiting mTOR and AKT phosphorylation.[@b24-ott-9-5023]

Prognostic value of PD-L1 in malignancies
=========================================

[Table 1](#t1-ott-9-5023){ref-type="table"} summarizes the studies on the prognostic value of PD-L1 in different malignancies. Some malignancies such as hepatocellular carcinoma, pancreatic cancer (PC), gastric cancer, RCC, esophageal cancer (EC), and ovarian cancer can generate an immunosuppressive tumor microenvironment by expressing high-aggregate PD-L1 to avoid cytolysis by activated T cells. It may explain why overexpression of high-aggregate PD-L1 in tumors leads to poor prognosis in cancer patients. Interestingly, several long-term follow-up investigations have found an inverse correlation between PD-L1 expression on tumor cells and poor prognosis of patients. Additionally, in lung cancer, colorectal cancer (CRC), and melanoma, PD-L1 expression has both positive and negative prediction values. In thymoma and thymic carcinoma, squamous cell carcinoma of the lung, and cervical cancer, PD-L1 expression alone is not of prognostic value but is of significant prediction value when combined with other indicators such as CD8^+^/Foxp3^+^ T cell ratio.

Lung cancer
-----------

Two studies demonstrated that PD-L1 expression on tumor cells is correlated with poor prognosis in NSCLC patients. Both the studies detected PD-L1 expression both on membrane and in cytoplasm of tumor cells, but the cut-off value for PD-L1 immunohistochemistry (IHC) positivity was not mentioned.[@b25-ott-9-5023],[@b26-ott-9-5023] Azuma et al[@b26-ott-9-5023] revealed that expression of high-aggregate PD-L1 on tumor cells is associated with EGFR gene mutations. Mu et al[@b25-ott-9-5023] evaluated the intensity of PD-L1 expression in 109 NSCLC specimens. By IHC analysis, strong association was found between PD-L1 expression and shorter survival time in adenocarcinoma patients.

Two other studies showed a positive correlation between better clinical outcomes and PD-L1 expression. Velcheti et al[@b27-ott-9-5023] assessed the predictive value of PD-L1 expression in two cohorts with 204 and 340 specimens, respectively. Tumor PD-L1 expression was found in 36% (Greek) and 25% (Yale) of the cases. Patients with PD-L1 expression above the detection threshold showed significantly better outcome. In 2014, Yang et al[@b28-ott-9-5023] reported that patients with positive PD-L1 expression on tumor cell membrane had better relapse-free survival. Importantly, Boland et al[@b29-ott-9-5023] showed that PD-L1 is not of independent prognostic value in squamous cell carcinoma of the lung. Based on the above studies, we conclude that PD-L1 has controversial predictive function in lung cancer.

Gastric cancer
--------------

Three articles reported the negative prediction value of PD-L1 in gastric cancer patients. Hou et al[@b30-ott-9-5023] found that 70 of 111 patients had positive PD-L1 expression either on membrane or in the cytoplasm of tumor cells, and there was a positive correlation between the expression of PD-L1 and poor prognosis. The cut-off value was 10% in their study. The study by Hou et al also demonstrated that the combination of increased number of Foxp3^+^ Tregs and increased expression of PD-L1 is an even stronger predictor of lower overall survival (OS) rate and worse prognosis as compared to each individual factor alone. The other two studies did not mention the cut-off values of PD-L1 IHC staining; both of them showed that PD-L1 is of independent prognostic value.[@b31-ott-9-5023],[@b32-ott-9-5023] Wu et al[@b31-ott-9-5023] examined 43 of 102 specimens and found that PD-L1 expression is mainly in the cytoplasm of tumor cells. Qing et al[@b32-ott-9-5023] showed that 54 of 107 cases had positive PD-L1 expression. Both studies demonstrated that PD-L1 expression is significantly associated with invasion and lymph node metastasis, which are poor prognostic factors of tumors. In conclusion, gastric cancer patients with positive PD-L1 expression have a significantly poorer prognosis than PD-L1-negative patients.

Colorectal cancer
-----------------

PD-L1 expression in CRC has not been fully addressed so far. Nevertheless, a strong correlation between PD-L1 expression on tumor cells and discrepant clinical outcomes has been observed. In CRC gene spectrum, DNA mismatch repair (MMR) status, known as MMR proficient and MMR deficient, has clinical significance in predicting the prognosis upon PD-L1 expression on tumor cells.[@b33-ott-9-5023] MMR-proficient tumors are characterized by concurrent expression of MLH1, MSH2, and MSH6, whereas MMR-deficient tumors are characterized by lacking of expression of at least one of these markers.[@b34-ott-9-5023] Droeser et al[@b33-ott-9-5023] analyzed PD-L1 expression in two subtypes of CRCs, including 1,197 MMR-proficient and 223 MMR-deficient CRCs. They detected strong PD-L1 expression in 37% of MMR-proficient and in 29% of MMR-deficient CRCs. PD-L1 expression is associated with improved survival in MMR-proficient CRCs, which might be due to concomitant increase of CD8^+^ T cells infiltration.

In contrast, another two studies showed that positive PD-L1 expression in tumor is an independent predictor of poor CRC prognosis.[@b22-ott-9-5023],[@b35-ott-9-5023] Thus, the predictive value of PD-L1 expression on tumor cells is controversial in CRC patients.

Esophageal cancer
-----------------

Positive correlation between PD-L1 expression and poor prognosis in EC was reported by two studies.[@b36-ott-9-5023],[@b37-ott-9-5023] Ohigashi et al[@b36-ott-9-5023] selected 10% as cut-off value and illustrated that 18 of 41 positive cases express PD-L1 or PD-L2 on the plasma membrane and in the cytoplasm of cancer cells. Although no significant correlation was found between PD-L1 expression and number of tumor-infiltrating T lymphocytes, PD-L2 expression was found to be inversely correlated with number of tumor-infiltrating CD8^+^ T cells. They also found that the expression of either PD-L1 or PD-L2 has significant prognostic value and the combination of expression of PD-L1 and PD-L2 leads to significantly poorer prognosis in postoperative EC patients. Their result further demonstrates that the roles of PD-L1 and PD-L2 in tumor immune escape differ depending on tumor types.

In a study carried out by Chen et al,[@b37-ott-9-5023] PD-L1 expression was found to be significantly associated with the infiltrating density of Foxp3^+^ Tregs, but the cut-off value of PD-L1 expression was not mentioned. They concluded that membrane PD-L1, but not nuclear PD-L1, expression is associated with poor OS in EC patients.

Pancreatic cancer
-----------------

Four studies focused on PC have achieved similar results showing that PD-L1 expression in human pancreatic carcinoma tissues is associated with poor prognosis. Nomi et al[@b8-ott-9-5023] recruited 51 PC patients and selected 10% as cut-off value of PD-L1 expression on tumor cells. They observed that PD-L1 expression is inversely correlated with number of tumor-infiltrating T lymphocytes, particularly CD8^+^ T cells, which might be a reason for the poor prognosis of PD-L1^+^ patients. Similarly, Wang et al[@b38-ott-9-5023] also found that PD-L1 inhibits activation of CD4^+^ and CD8^+^ T cells in tumor microenvironment in spite of selecting 5% as cut-off value for PD-L1 expression. Inhibition of effector T cell function could promote tumor growth, which may explain the poor prognosis of PD-L1-positive patients. Chen et al[@b39-ott-9-5023] confirmed that PD-L1 is an independent factor of poor prognosis and its expression is significantly associated with the stage of the tumor and preoperative serum CA199 level. Geng et al[@b40-ott-9-5023] found that PD-L1 overexpression in human pancreatic carcinoma tissues might have associations with tumor progression and invasiveness, which has significant correlation with poor OS. Collectively, PD-L1 expression is correlated with poor clinical outcomes in PC.

PD-L1 expression as a predictive biomarker in cancer therapy
============================================================

PD-1/PD-L1 pathway is a significant mechanism of immune suppression within tumor microenvironment. mAbs targeting PD-1 or PD-L1 could block the PD-1/PD-L1 pathway and enhance T cell functions. Thus, mAbs to PD-1 and PD-L1, as well as PD-L2 fusion protein, are widely tested in different clinical trials. Pidilizumab, lambrolizumab, nivolumab, and AMP-224 are mAbs targeting PD-1, whereas BMS-936559, MEDI4736, MPDL3280A, and MSB0010718C are mAbs to PD-L1.[@b41-ott-9-5023] These mAbs were used in the treatment of malignancies including melanoma, NSCLC, RCC, bladder cancer, CRC, and gastric cancer. The overall response rates achieved was 16%--100%.[@b3-ott-9-5023],[@b42-ott-9-5023] Consequently, an effective predictive biomarker is needed to select "real" patients who will benefit from cancer immunotherapy while avoiding unnecessary toxicity. Tumor PD-L1 expression as a predictive biomarker has been evaluated in many clinical trials. For example, CheckMate 037[@b43-ott-9-5023] study confirmed that nivolumab has better clinical efficacy than chemotherapy. Weber et al[@b43-ott-9-5023] randomly allocated 272 patients to nivolumab and 133 to investigator's choice of chemotherapy. The pretreatment PD-L1-positive number was 134 (49%) and 67 (50%), respectively. Confirmed objective response rate (ORR) was found in 31.7% of the first 120 patients in the nivolumab group versus 10.6% of 47 patients in the group that received investigator's choice of chemotherapy. Importantly, the complete response rates were 3.3% versus 0%. A Phase I expansion study was implemented by Powles et al[@b44-ott-9-5023] to investigate the responsiveness of PD-L1-positive and PD-L1-negative patients to MPDL3280A. The PD-L1-positive patients achieved 43% (95% confidence interval \[CI\]: 26%--63%) response rate, whereas the PD-L1-negative patients achieved a response rate of 11% (95% CI: 4%--26%), demonstrating the therapeutic activity of MPDL3280A in PD-L1-positive patients with urothelial bladder cancer. Both the studies demonstrated that tumor PD-L1 expression is an effective predictor of the outcomes of cancer immunotherapy. Nevertheless, the predictive value of PD-L1 is not consistent in cancer patients. For instance, in Phase III trials of CheckMate 017[@b45-ott-9-5023] and CheckMate 057,[@b46-ott-9-5023] the clinical efficacy of nivolumab versus docetaxel in previously treated advanced or metastatic squamous NSCLC and non-squamous NSCLC was evaluated, respectively. The nivolumab group achieved longer OS (9.2 versus 6.0 months \[*P*=0.00025\] and 12.2 versus 9.4 months \[*P*=0.0015\], respectively) and higher ORR (20% versus 9% \[*P*=0.0083\] and 19% versus 12% \[*P*=0.0246\], respectively) than patients treated with doc-etaxel in two studies, but the better progression-free survival was only achieved in squamous NSCLC (CheckMate 017).[@b45-ott-9-5023] Importantly, the beneficial effect of nivolumab in squamous NSCLC is irrelevant to PD-L1 expression, whereas in non-squamous NSCLC, PD-L1 expression is predictive of the benefit of nivolumab.[@b46-ott-9-5023] Moreover, some PD-L1-negative patients also respond to PD-1/PD-L1 blockade therapy. Therefore, using tumor PD-L1 expression as exclusionary predictive biomarker for the outcome of PD-1/PD-L1 blockade therapy has its limitations.[@b47-ott-9-5023]

mAbs targeting PD-1/PD-L1 pathway have achieved impressive response rates in patients with melanoma, NSCLC, RCC, and bladder cancer, and the value of PD-L1 as a predictive biomarker for the outcomes of mAb therapy has been demonstrated in many studies.[@b3-ott-9-5023]--[@b5-ott-9-5023] Other predictive biomarkers for the prognosis of PD-L1 mAb immunotherapy in cancers have also been investigated. In 2015, ASCO, a Phase II study, confirmed the first gene predictive biomarker -- MMR deficiency could effectively predict PD-1 blockade efficacy. In 41 patients with or without MMR deficiency, the ORR was 40% for MMR-deficient CRC patients and 0% for MMR-proficient CRC patients. The progression-free survival rate was 78% for MMR-deficient CRC patients and 11% for MMR-proficient CRC patients.[@b48-ott-9-5023] More biomarkers should be investigated to facilitate the accurate selection of patients who can benefit from PD-1/PD-L1 blockade therapy.

Explanations of PD-L1 prognostic and predictive value
=====================================================

IHC-based detection of PD-L1 has limitations because of its subjectivity in determining a clear definition of "positive" tumor PD-L1 staining.[@b49-ott-9-5023],[@b50-ott-9-5023] Antibodies used in different studies include M1H1, 5H1, 5H1-A3, 2H11, 27A2, 405.9A11, and E1L3N.[@b6-ott-9-5023],[@b10-ott-9-5023],[@b12-ott-9-5023],[@b31-ott-9-5023],[@b33-ott-9-5023],[@b51-ott-9-5023],[@b52-ott-9-5023] Different PD-L1 antibody clones can be a reason for lower PD-L1 expression in some studies. In addition to technical issues with IHC, temporal and spatial factors should also be considered when assessing PD-L1 in cancers. Specimens that were obtained when PD-L1 overexpression in tumor microenvironment has already taken place or patients' specimens that missed the pertinent tumor--immune interface may lead to a bias in PD-L1's predictive value in cancers.[@b53-ott-9-5023] Furthermore, interferon-γ secreted by tumor-infiltrating lymphocytes may cause upregulation of PD-L1 on tumor cells, leading to the induction of T cell apoptosis via PD-L1 and PD-1 interaction. Collectively, the prognostic value of PD-L1 IHC relies on the time of biopsy that is associated with the development of the nidus and is related to previous therapies including chemotherapy or radiotherapy. Deng et al[@b54-ott-9-5023] demonstrated that tumor PD-L1 expression is upregulated after irradiation in mouse models. Therefore, single-time point evaluation of PD-L1 expression may not reflect the real condition, and multiple sites sampling is necessary for the determination of PD-L1 expression.

Spatial impact is another consideration when assessing PD-L1 expression in cancers. PD-L1 expression status may differ in primary lesions versus metastatic lesions due to tumor heterogeneity. PD-L1 expression has two patterns, focal expression and diffuse expression.[@b55-ott-9-5023] Even from the same sample, impertinent biopsy may result in a bias due to the focal nature of PD-L1 expression in many tumors. Assessment of PD-L1 expression in tumor or peritumor is also a question. Thus, selection of the optimum site for biopsy for assessing PD-L1 expression status remains challenging and needs further studies.

Difficulties in comparing different, sometimes even contrary, results also arise from the following considerations: available data are retrospective, patients have different clinical characteristics, tumor samples from different tumor types or different locations of the same tumor are heterogeneous, and PD-L1 positivity is defined by membrane and/or cytoplasmic PD-L1 immunostaining. Several studies have demonstrated that only cell membrane-expressed PD-L1 has biological significance.[@b56-ott-9-5023] Therefore, it is more reasonable to analyze correlations between membrane PD-L1 protein, rather than intracellular PD-L1 protein or mRNA, and clinical outcomes.

MMR, the first gene predictive biomarker that bridges the immunotherapy and genomics, effectively predicts PD-1 blockade efficacy in various cancers. It is necessary to develop more genetic methods to improve the effective prediction of cancer immunotherapy, and select "real" patients who are most likely to benefit from the immunotherapy. As the candidates of predictive marker, CD8^+^ T lymphocytes and IFN-γ may be evaluated in consideration of their importance in tumor microenvironment.

Conclusion
==========

Studies have demonstrated that binding of tumor PD-L1 to its receptor PD-1 on T cell surface inhibits infiltrating T cell activation and subsequent lysis of tumor cells. PD-L1 expression in tumors strongly correlates with poor prognosis in gastric cancer, hepatocellular carcinoma, RCC, EC, PC, and ovarian cancer.[@b30-ott-9-5023],[@b37-ott-9-5023],[@b39-ott-9-5023],[@b57-ott-9-5023]--[@b59-ott-9-5023] However, opposite results have been observed in breast cancer and merkel cell carcinoma, where tumor PD-L1 expression correlates with a better prognosis.[@b60-ott-9-5023],[@b61-ott-9-5023] In lung cancer, CRC, and melanoma, PD-L1 expression has both positive and negative prediction value.[@b33-ott-9-5023],[@b35-ott-9-5023],[@b62-ott-9-5023]--[@b64-ott-9-5023] The controversy in PD-L1's diagnostic and predictive value may be due to the following reasons. First, IHC-based detection of PD-L1 has technical issues, and the results may not accurately reflect the real PD-L1 expression status. Second, detection of PD-L1 expression in tumors is affected by temporal and spatial factors, leading to erroneous interpretation of the results. In addition, PD-L1 expression heterogeneity should also be taken into consideration. All these factors illustrate the limitation of using tumor PD-L1 expression as an exclusive biomarker for cancer immunotherapy. However, we cannot ignore the value of PD-L1 expression in selecting patients who will benefit from immunotherapy. Many clinical trials have demonstrated that immunotherapy significantly improves progression-free survival in patients. Remarkably, the grade 3 or 4 adverse events were evidently decreased compared to chemotherapy.[@b45-ott-9-5023],[@b91-ott-9-5023]--[@b93-ott-9-5023]

Other effective biomarkers such as gene marker or combined indexes and improved understanding of tumor microenvironment are needed to accurately determine which patients will benefit from PD-1/PD-L1 pathway blockade therapy and to avoid the unnecessary autoimmune side effects from overtreatment.
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Prognostic value of PD-L1 in different malignancies

  Disease                                 N             Detection method; PD-L1 detection antibody                                                                                                           Location of PD-L1 expression                                                                                                                        PD-L1 tumor surface expression cut-off for positivity   TIL or other immunocytes associated with PD-L1 expression                                                                                                                                                              Other clinicopathological factors associated with PD-L1 expression                                                                                                                                                                                                                                         Clinical outcomes                                                                                                                                                                                                                                                          Study
  --------------------------------------- ------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------
  Thymoma and thymic carcinoma            101 and 38    Paraffin IHC; anti-PD-L1 (clone E1L3N)                                                                                                               70% of thymic carcinoma (type C) and 23% of thymoma (types A, AB, and B) samples were positive for PD-L1                                            1%                                                      NA                                                                                                                                                                                                                     Higher PD-L1 expression was more likely to exhibit male, more advanced pathological features, including WHO classification type and Masaoka--Koga stage                                                                                                                                                    PD-L1 positivity was not a significant negative factor of OS                                                                                                                                                                                                               Katsuya et al[@b6-ott-9-5023]
  Adrenocortical carcinoma                28            Paraffin IHC; monoclonal anti-PD-L1 antibody (405.9A11)                                                                                              PD-L1 expression was detected both on tumor cell membrane and in TIMCs                                                                              5%                                                      NA                                                                                                                                                                                                                     PD-L1 positivity on either tumor cell membrane or in TIMCs was not significantly associated with higher stage at diagnosis, higher tumor grade, and excessive hormone secretion                                                                                                                            PD-L1 expressed on both tumor cell membrane and in TIMCs with no relationship with 5-year OS                                                                                                                                                                               Fay et al[@b9-ott-9-5023]
  Head and neck squamous cancer           24            Frozen IHC; anti-PD-L1 (5H1)                                                                                                                         Eleven of 24 specimens had intracytoplasmic staining, eleven of 24 tumors had membrane reactivity, and ten of 24 had both                           NA                                                      NA                                                                                                                                                                                                                     16 of 24 specimens had PD-L1 staining                                                                                                                                                                                                                                                                      NA                                                                                                                                                                                                                                                                         Strome et al[@b10-ott-9-5023]
  Malignant brain tumors                  83            FACS; anti-PD-L1 (BD Pharmingen Inc., San Diego, CA, USA)                                                                                            61% of brain tumors (but no WHO grade 1 tumors) expressed PD-L1                                                                                     NA                                                      NA                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Jacobs et al[@b11-ott-9-5023]
  Glioma                                  54            Frozen IHC; anti-PD-L1 (clone MIH1; eBioscience, San Diego, CA, USA)                                                                                 NA                                                                                                                                                  NA                                                      NA                                                                                                                                                                                                                     PD-L1 expression was closely correlated with the grade of the tumor                                                                                                                                                                                                                                        NA                                                                                                                                                                                                                                                                         Wilmotte et al[@b12-ott-9-5023]
                                          10            Frozen IHC; anti-PD-L1 (5H1)                                                                                                                         Strong PD-L1 expression was detected in all ten glioma samples examined                                                                             NA                                                      NA                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Wintterle et al[@b82-ott-9-5023]
  Lung cancer                             109           Paraffin IHC; anti-PD-L1 (clone not specified)                                                                                                       PD-L1 expression on membrane and in cytoplasm of tumors with cluster and scattered patterns                                                         NA                                                      CD1α^+^ TIDC was increased in PD-L1^+^ portions of tumor and had higher expression of PD-L1 than CD83^+^ DCs                                                                                                           PD-L1^+^ cells in adenocarcinoma were more than in squamous cell carcinoma                                                                                                                                                                                                                                 PD-L1 positivity correlated with survival shorter than 3 years after lobectomy                                                                                                                                                                                             Mu et al[@b25-ott-9-5023]
                                          164           Paraffin IHC; anti-PD-L1 (Lifespan Biosciences, Seattle, WA, USA); flow cytometry                                                                    PD-L1 was detected on membrane or in the cytoplasm (or both) of tumor cells and stromal lymphocytes in the surgically resected tumor specimens      NA                                                      NA                                                                                                                                                                                                                     PD-L1 expression is significantly higher in females, never smokers, those with adenocarcinoma histology, and those with EGFR mutations                                                                                                                                                                     PD-L1 overexpression was associated with a significantly shorter OS for NSCLC patients and had independent negative prognostic value                                                                                                                                       Azuma et al[@b26-ott-9-5023]
                                          204 and 340   Paraffin IHC; anti-PD-L1 (clone 5H1)                                                                                                                 NA                                                                                                                                                  NA                                                      PD-L1 protein and mRNA expression was consistently associated with increased local lymphocytic infiltrate                                                                                                              In Greek cohort, PD-L1 expression had association with tumor stage and inflammation, while in Yale cohort, with histology and inflammation                                                                                                                                                                 Patients with PD-L1 expression above the detection threshold showed statistically significant better outcome                                                                                                                                                               Velcheti et al[@b27-ott-9-5023]
                                          163           Paraffin IHC; anti-PD-L1 (Proteintech Group Inc., Chicago, IL, USA)                                                                                  PD-L1 expressed on membrane of tumor cells                                                                                                          5%                                                      The degree of T lymphocytes infiltration was slightly higher in PD-L1-positive tumors than in PD-L1-negative ones                                                                                                      Higher PD-L1 expression was correlated with higher grade differentiation and vascular invasion                                                                                                                                                                                                             Positive PD-L1 expression had better RFS. Advanced-stage and positive VPSI were significant risk factors for poor prognosis of OS                                                                                                                                          Yang et al[@b28-ott-9-5023]
                                          214           Paraffin IHC; anti-PD-L1 (clone 5H1, laboratory developed)                                                                                           PD-L1 predominately expressed on membrane and minimally expressed in cytoplasm                                                                      5%                                                      PD-L1 expression had no significant correlation with infiltrating lymphocytes                                                                                                                                          NA                                                                                                                                                                                                                                                                                                         PD-L1 was not of independent prognostic value in squamous cell carcinoma of the lung                                                                                                                                                                                       Boland et al[@b29-ott-9-5023]
                                          120 and 10    Paraffin IHC; anti-PD-L1                                                                                                                             NA                                                                                                                                                  NA                                                      NA                                                                                                                                                                                                                     PD-L1 overexpression was related to poor tumor cell differentiation and advanced TNM stage                                                                                                                                                                                                                 PD-L1^--^ NSCLC patients had longer overall 5-year survival than PD-L1^+^ patients. PD-L1 status had independent prognostic value of NSCLC                                                                                                                                 Chen et al[@b62-ott-9-5023]
                                          52            Frozen IHC; anti-B7-H1 (MIH1)                                                                                                                        PD-L1 expression in cytoplasm or on membrane or both, in focal or scattered patterns in all 52 specimens of NSCLC                                   NA                                                      In a subset of five patients, the amount of T lymphocytes infiltration was significantly reduced in PD-L1-expressing tumor regions                                                                                     No correlation was observed between PD-L1 expression and clinicopathological characteristics                                                                                                                                                                                                               No correlation between PD-L1 expression and patient survival                                                                                                                                                                                                               Konishi et al[@b81-ott-9-5023]
  Gastric cancer                          111           Paraffin IHC; anti-Foxp3^+^ (polyclonal antibody, Sigma-Aldrich Co., St Louis, MO, USA) and anti-PD-L1 (polyclonal antibody; Abcam, Cambridge, UK)   70 of 111 cases demonstrated PD-L1 expression on the membrane or in the cytoplasm                                                                   10%                                                     Significant correlation was found between the infiltration of Foxp3^+^ Tregs and the expression of PD-L1 on the tumor cells and TILs                                                                                   High-level Foxp3^+^ Tregs and PD-L1 expression led to lymph node metastasis and an advanced clinicopathological stage                                                                                                                                                                                      Enhanced expression of Foxp3^+^ Tregs and PD-L1 exhibited a lower OS rate and a worse prognosis                                                                                                                                                                            Hou et al[@b30-ott-9-5023]
                                          102           Paraffin IHC; anti-B7-H1 (2H11)                                                                                                                      PD-L1 was expressed mainly in the cytoplasm; some nuclear membrane localization was also present                                                    NA                                                      NA                                                                                                                                                                                                                     42.2% of gastric carcinoma tissues were PD-L1^+^. PD-L1 correlated with tumor size, invasion, and lymph node metastasis                                                                                                                                                                                    PD-L1 expression was an independent prognostic factor and correlated with poorer survival                                                                                                                                                                                  Wu et al[@b31-ott-9-5023]
                                          107           Paraffin IHC; anti-PD-L1 (polyclonal antibody)                                                                                                       54 of 107 cases had positive PD-L1 expression                                                                                                       NA                                                      NA                                                                                                                                                                                                                     Positive PD-L1 expressions were significantly associated with depth of invasion, lymph node metastasis, pathological type, higher T stage, and higher differentiation                                                                                                                                      PD-L1-positive gastric cancers were significantly associated with a poor prognosis                                                                                                                                                                                         Qing et al[@b32-ott-9-5023]
                                          205           Paraffin IHC, FACS; anti-PD-L1                                                                                                                       88 of 205 gastric carcinoma tissues were PD-L1 positive and were mainly distributed in cytoplasm and on membrane of the tumor cells                 NA                                                      IFN-γ and CD3^+^ T cells infiltration was found in carcinoma tissues                                                                                                                                                   High PD-L1 expression was correlated with age, carcinoma location, and differentiation                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                         Jiang et al[@b83-ott-9-5023]
  CRC                                     143           Paraffin IHC; anti-PD-L1 (ab58810; Abcam)                                                                                                            64 patients (44.8%) showed positive PD-L1 expression in the cytoplasm and on the membrane                                                           NA                                                      NA                                                                                                                                                                                                                     PD-L1 was significantly associated with cell differentiation status and TNM stage                                                                                                                                                                                                                          Positive PD-L1 expression showed a trend of shorter survival time; PD-L1 expression is an independent predictor of colorectal carcinoma prognosis                                                                                                                          Shi et al[@b22-ott-9-5023]
                                          1,491         Paraffin IHC; anti-PD-L1 mAb (clone 27A2; MBL International Corporation, Woburn, MA, USA)                                                            Strong PD-L1 expression was observed in 37% of MMR-proficient and in 29% of MMR-deficient CRCs                                                      NA                                                      In MMR-proficient CRC, correlation between strong PD-L1 expression and infiltration by CD8^+^ lymphocytes was found                                                                                                    PD-L1 expression in MMR-proficient CRC was significantly associated with early T stage, absence of lymph node metastases, lower tumor grade, and absence of vascular invasion                                                                                                                              PD-L1 expression was paradoxically associated with improved survival in MMR-proficient CRC                                                                                                                                                                                 Droeser et al[@b33-ott-9-5023]
                                          185           Paraffin IHC; polyclonal anti-PD-L1 antibody                                                                                                         PD-L1 was expressed in cytoplasm and on membrane of the tumor cells                                                                                 NA                                                      CD3^+^ T cells in PD-L1^+^ specimens were significantly lower than that in PD-L1^−^ patients but no difference of CD8^+^ T cells                                                                                       Positive tumor PD-L1 expression was associated with lymph node metastasis                                                                                                                                                                                                                                  High PD-L1 was closely correlated with poor prognosis                                                                                                                                                                                                                      Liang et al[@b35-ott-9-5023]
                                          56            Paraffin IHC; anti-PD-L1                                                                                                                             Cytoplasm and/or membrane                                                                                                                           NA                                                      A significant correlation between Tregs infiltration and PD-L1 expression was found                                                                                                                                    PD-L1 expression was positively correlated to the infiltration depth, lymph node metastasis, and advanced Duke's stage                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                         Zhao et al[@b85-ott-9-5023]
  Esophageal cancer                       41            Frozen IHC, mRNA analysis; anti-PD-L1 (MIH1, mouse immunoglobulin G1)                                                                                18 of 41 positive cases expressed PD-L1 or PD-L2 on the plasma membrane and in the cytoplasm of cancer cells                                        10%                                                     No significant correlation was found between PD-L1 expression and tumor-infiltrating T lymphocytes. PD-L2 expression was inversely correlated with tumor-infiltrating CD8^+^ T cells                                   PD-L1-positive status was associated with advanced stage of cancer with positive lymph node metastasis and distant metastasis                                                                                                                                                                              PD-L1 and PD-L2 expression led to significantly poorer prognosis                                                                                                                                                                                                           Ohigashi et al[@b36-ott-9-5023]
                                          99            Paraffin IHC, FACS; anti-PD-L1 (NBP1-03220; Novus International, St Louis, MO, USA)                                                                  82 of 99 patients demonstrated positive membranous/cytoplasmic PD-L1 staining, and 79 of 99 patients demonstrated positive nuclear PD-L1 staining   NA                                                      PD-L1 expression was found significantly associated with the infiltrating density of Foxp3^+^ Tregs                                                                                                                    Membranous or cytoplasmic PD-L1 expression was correlated with tumor invasion depth, and not correlated with other clinicopathological factors. Nuclear PD-L1 expression was significantly correlated with tumor invasion depth                                                                            Positive PD-L1 expression on membrane or in cytoplasm led to poorer OS but positive nuclear PD-L1 staining did not                                                                                                                                                         Chen et al[@b37-ott-9-5023]
  Pancreatic cancer                       51            Frozen IHC, FACS; anti-human PD-L1 (MIH1, mouse immunoglobulin G1)                                                                                   PD-L1 was expressed mainly on the plasma membrane and in the cytoplasm of cancer cells                                                              10%                                                     PD-L1 expression was inversely correlated with tumor-infiltrating T lymphocytes, particularly CD8^+^ T cells                                                                                                           There was no significant correlation between tumor PD-L1 status and clinical indicators including tumor status, nodal status, metastatic status, and pathologic stage                                                                                                                                      PD-L1^+^ patients had a significantly poorer prognosis than the PD-L1^−^ patients. PD-L1 was an independent prognostic factor                                                                                                                                              Nomi et al[@b8-ott-9-5023]
                                          81            Paraffin IHC; anti-PD-L1 (MIH1; eBioscience)                                                                                                         PD-L1 was located primarily in the cytoplasm                                                                                                        5%                                                      PD-L1 resulted in the inhibition of CD4^+^ and CD8^+^ T-cell activation and promotion of tumor growth                                                                                                                  PD-L1 significantly correlated with the pathological grade and TNM stage                                                                                                                                                                                                                                   PD-L1-positive status was a prognostic indicator of poor disease-specific survival                                                                                                                                                                                         Wang et al[@b38-ott-9-5023]
                                          40 and 10     Paraffin IHC; anti-PD-L1 (monoclonal number: 2H11)                                                                                                   PD-L1 was intensely expressed in pancreatic carcinoma tissues, and weakly expressed in cytoplasm of islet cells                                     10%                                                     NA                                                                                                                                                                                                                     PD-L1 expression was significantly associated with the staging of tumor and preoperative serum CA199 level                                                                                                                                                                                                 PD-L1 was an independent factor for poor prognosis                                                                                                                                                                                                                         Chen et al[@b39-ott-9-5023]
                                          40 and 8      Paraffin IHC; anti-PD-L1 (clone 130002; R&D Systems, Inc., Minneapolis, MN, USA)                                                                     PD-L1 was located primarily in the cytoplasm of the tumor cells                                                                                     NA                                                      NA                                                                                                                                                                                                                     PD-L1 expression was significantly associated with poor tumor differentiation and advanced tumor stage                                                                                                                                                                                                     PD-L1 overexpression in human pancreatic carcinoma tissues might have associations with tumor progression and invasiveness                                                                                                                                                 Geng et al[@b40-ott-9-5023]
  Malignant pleural mesothelioma          106           Paraffin IHC; anti-PD-L1 (clone 5H1-A3)                                                                                                              Cytoplasmic and/or membranous                                                                                                                       5%                                                      NA                                                                                                                                                                                                                     PD-L1 positivity was less likely to undergo therapeutic surgery and more likely to be a sarcomatoid mesothelioma subtype                                                                                                                                                                                   PD-L1 was expressed in a substantial proportion of malignant pleural mesotheliomas and was associated with poor survival                                                                                                                                                   Mansfield et al[@b51-ott-9-5023]
  Merkel cell carcinoma                   67            Paraffin IHC; anti-PD-L1 (5H1)                                                                                                                       PD-L1 expressed on membrane of tumor cells and TILs                                                                                                 5%                                                      A high density of CD8^+^ cells was associated with PD-L1 expression by tumor cells and by TILs                                                                                                                         Expression of PD-L1 by either tumor cells or infiltrating immune cells did not correlate with patient's sex, age, or pathologic stage                                                                                                                                                                      Tumor cell PD-L1 expression, but not TIL PD-L1 expression, was associated with improved OS                                                                                                                                                                                 Lipson et al[@b61-ott-9-5023]
  MEL                                     59            Paraffin IHC; anti-B7-H1 (clone 27A2, MBL International Corporation)                                                                                 PD-L1 expressed in tumor cell cytoplasm                                                                                                             NA                                                      NA                                                                                                                                                                                                                     Higher PD-L1 expression was found in high tumor stage, primary tumors with lymphonodus metastasis, and metastatic lymphonodus                                                                                                                                                                              PD-L1 expression was an independent predictor of poor OS and DFS                                                                                                                                                                                                           Hino et al[@b63-ott-9-5023]
                                          150           Paraffin IHC; anti-PD-L1 mAb (5H1)                                                                                                                   Membranous PD-L1 expression by melanocytes within the tumors and in the TILs                                                                        5%                                                      Almost all PD-L1^+^ tumors were associated with TILs, whereas only 28% of PD-L1^−^ tumors were associated with TIL                                                                                                     PD-L1 expression was associated with the superficial spreading and nodular MEL subtypes and not with MEL stage                                                                                                                                                                                             PD-L1 expression was associated with improved survival in metastatic MEL but not primary invasive MEL                                                                                                                                                                      Taube et al[@b64-ott-9-5023]
  Cervical cancer                         115           Paraffin IHC; anti-B7-H1 (5H1)                                                                                                                       PD-L1 expressed on tumor cell membrane and throughout tumor bed                                                                                     NA                                                      PD-L1 expression was associated with higher Foxp3^+^ T cells infiltration but not with CD8^+^ T cells                                                                                                                  In patients with PD-L1^+^ or PD-L1^−^ tumors, more than half of the infiltrating CD8^+^ T cells and half of the Foxp3^+^ T cells expressed PD-1                                                                                                                                                            PD-L1 expression had no independent prognosis value; OS of patients with PD-L1^+^ tumors and a low CD8^+^/Foxp3^+^ T cell ratio was better than in patients with a PD-L1^−^ tumor and a low CD8^+^/Foxp3^+^ T-cell ratio                                                   Karim et al[@b65-ott-9-5023]
  Bladder cancer                          50            Paraffin IHC; anti-human PD-L1 polyclonal antibody (Santa Cruz Biotechnology Inc., Dallas, TX, USA)                                                  PD-L1 expressed in the cytoplasm or on the membrane of tumor cells                                                                                  10%                                                     NA                                                                                                                                                                                                                     PD-L1 expression was strongly associated with the pathological grade, clinical stage, and recurrence of bladder cancer                                                                                                                                                                                     PD-L1-positive group had a lower survival rate than negative group. PD-L1 was of independent prognostic value in bladder cancer                                                                                                                                            Wang et al[@b68-ott-9-5023]
  Differentiated thyroid carcinoma        407           Paraffin IHC; anti-PD-L1 polyclonal antibody (prediluted; ab82059; Abcam)                                                                            PD-L1 expression was detected in the cytoplasm of tumor cells                                                                                       NA                                                      Elevated levels of PD-L1 protein were associated with the presence of CD4^+^, CD8^+^, CD20^+^, and Foxp3^+^ lymphocytes                                                                                                Elevated levels of PD-L1 protein were associated with tumor-associated macrophages, and the presence of myeloid-derived suppressor cells. Higher PD-L1 mRNA level was associated with stages II--IV and higher age                                                                                         PD-L1 positivity had no prognostic value                                                                                                                                                                                                                                   Cunha et al[@b69-ott-9-5023]
  Sarcoma                                 50            Paraffin IHC; anti-PD-L1                                                                                                                             PD-L1 expressed on plasma membrane                                                                                                                  1%                                                      Positive tumor PD-L1 expression and lymphocytic PD-L1 expression were associated with high-density CD8^+^ cells                                                                                                        PD-L1 expression had no association with various clinicopathological factors                                                                                                                                                                                                                               There was no association between OS and PD-L1 expression in tumor or immune infiltrates                                                                                                                                                                                    D'Angelo et al[@b70-ott-9-5023]
  Oropharyngeal squamous cell carcinoma   181           Paraffin IHC; anti-PD-L1 (clone A3)                                                                                                                  84 of 181 positive cases demonstrated both membranous and cytoplasmic staining                                                                      5%                                                      NA                                                                                                                                                                                                                     PD-L1 expression was associated with worse N stage and distant metastasis                                                                                                                                                                                                                                  No correlation was found between PD-L1 expression and patient survival                                                                                                                                                                                                     Ukpo et al[@b71-ott-9-5023]
  ICC                                     31            Paraffin IHC, functional assays; anti-PD-L1 (Abcam)                                                                                                  Varying degrees of PD-L1 expression on plasma membrane and in cytoplasm of cancer cells were found in all 31 ICC cases                              NA                                                      Tumor-infiltrating CD8^+^ lymphocytes were significantly lower in III--IV and poorly differentiated tumors. A significant inverse correlation between tumor-related PD-L1 expression and CD8^+^ TILs count was found   Tumor-related PD-L1 expression was significantly correlated with a poorer histological differentiation and a more advanced pTNM stage                                                                                                                                                                      NA                                                                                                                                                                                                                                                                         Ye et al[@b72-ott-9-5023]
  Multiple myeloma                        82            FACS, Western blot analysis, mRNA analysis; anti-PD-L1 (M1H1 for FACS, N20 for Western blot analysis)                                                PD-L1 was detected in most multiple myeloma plasma cell samples                                                                                     NA                                                      NA                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Liu et al[@b73-ott-9-5023]
  Leukemia                                30            FACS, functional assays, frozen IHC; anti-PD-L1 (5H1)                                                                                                17 of 30 samples of human leukemia cells were B7-H1^+^                                                                                              NA                                                      NA                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Salih et al[@b74-ott-9-5023]
                                          60            Real-time PCR, IHC; anti-PD-L1                                                                                                                       PD-L1 expressed mainly on the plasma membrane of cancer cells                                                                                       2.0 for real-time PCR                                   NA                                                                                                                                                                                                                     PD-L1 was significantly higher in the relapse M5 patients and those with complicated pulmonary infections                                                                                                                                                                                                  PD-L1 status was defined to be an independent prognostic factor; PD-L1-positive patients had a poorer prognosis than the negative patients                                                                                                                                 Chen et al[@b89-ott-9-5023]
  HCC                                     141           Paraffin IHC; anti-human PD-L1 (BioLegend, San Diego, CA, USA); FACS with PE-conjugated anti-PD-L1                                                   NA                                                                                                                                                  NA                                                      NA                                                                                                                                                                                                                     Circulating PD-L1 expression was closely correlated with intratumoral PD-L1 expression. PD-1/PD-L1 expression was associated with tumor size and blood vessel invasion                                                                                                                                     Patients with higher expression of circulating PD-L1 had a significantly shorter OS and tumor-free survival than those with lower expression                                                                                                                               Zeng et al[@b57-ott-9-5023]
                                          240 and 125   Paraffin IHC; anti-PD-L1 (eBioscience); Western blot analysis                                                                                        PD-L1 was shown on the cell membrane, in the cytoplasm, or both in a focal or scattered pattern                                                     NA                                                      Significant positive correlation between PD-L1 expression and Foxp3^+^ Treg cell infiltration was found                                                                                                                PD-L1 expression was an independent prognostic factor for tumor vascular invasion, encapsulation, and TNM stage                                                                                                                                                                                            Patients with PD-L1^+^ tumors had poorer DFS and OS than patients with PD-L1^−^ tumors; PD-L1 status was an independent prognostic factor for DFS, and PD-L1^+^ patients were nearly two times more likely to suffer from relapse after resection than PD-L1^−^ patients   Gao et al[@b75-ott-9-5023]
                                          56            Paraffin IHC, FACS; anti-PD-L1 (BioLegend); FACS with PE-conjugated PD-L1 (eBioscience)                                                              Cytoplasmic and membranous                                                                                                                          NA                                                      CD8^+^ T cells were mainly distributed around the PD-L1^+^ portion of tumor nest                                                                                                                                       NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Shi et al[@b76-ott-9-5023]
                                          26            Frozen IHC; anti-PD-L1 (MIH1; eBioscience)                                                                                                           PD-L1 was expressed on the membrane of tumor cells; focal or scattered                                                                              NA                                                      PD-1^+^ T cells accumulated within tumors and in peritumoral areas                                                                                                                                                     24 of 26 HCC specimens expressed PD-L1; PD-L1 expression was associated with hepatitis B virus infection and with earlier tumor stage                                                                                                                                                                      NA                                                                                                                                                                                                                                                                         Wang et al[@b84-ott-9-5023]
  RCC                                     429           Paraffin IHC; anti-PD-L1 (5H1)                                                                                                                       PD-L1 expression on both tumor cells and lymphocytes                                                                                                10%                                                     NA                                                                                                                                                                                                                     This combined PD-L1 expression was associated with regional lymph node involvement, distant metastases, nuclear grade, and histologic tumor necrosis, all of which have been shown to portend a poor prognosis                                                                                             Positive PD-L1 expression was close to three times more likely to die from RCC compared with negative PD-L1 expression patients. The combination of increased tumor cell PD-L1 and lymphocyte PD-L1 is an even stronger predictor of patient outcome                       Thompson et al[@b58-ott-9-5023]
                                          306           Paraffin IHC; anti-PD-L1 (5H1)                                                                                                                       NA                                                                                                                                                  5%                                                      NA                                                                                                                                                                                                                     PD-L1^+^ tumors were associated with TNM stage III or IV, tumor size of \$5 cm, nuclear grade 3 or 4, and coagulative tumor necrosis                                                                                                                                                                       Patients with PD-L1^+^ tumors had increased risk of death from RCC and overall mortality and decreased 5-year survival                                                                                                                                                     Thompson et al[@b66-ott-9-5023]
                                          196           Paraffin IHC; anti-PD-L1 (clone 5H1)                                                                                                                 PD-L1 expression on both tumor cells and lymphocytes                                                                                                10%                                                     NA                                                                                                                                                                                                                     High PD-L1 expression was associated with regional lymph node involvement, distant metastases, advanced nuclear grade, and tumor necrosis                                                                                                                                                                  Patients with high PD-L1 expression was significantly more likely to die of RCC                                                                                                                                                                                            Thompson et al[@b77-ott-9-5023]
  UCB                                     65            Frozen IHC; anti-PD-L1 (MIH1)                                                                                                                        PD-L1 present on plasma membrane and/or in cytoplasm of urothelial cancer cells in a focal pattern                                                  12.2%                                                   In 13 examined cases, most TILs expressed high levels of PD-1                                                                                                                                                          PD-L1 expression correlated with WHO grade and primary tumor classification                                                                                                                                                                                                                                Increased PD-L1 expression was associated with poor survival and increased possibility of postresection recurrence                                                                                                                                                         Nakanishi et al[@b7-ott-9-5023]
                                          160           Paraffin IHC; anti-PD-L1 (405.9A11)                                                                                                                  PD-L1 expressed on tumor cell membrane and TIMCs                                                                                                    5%                                                      NA                                                                                                                                                                                                                     PD-L1 expression had no association with various clinicopathological factors                                                                                                                                                                                                                               Positive PD-L1 expression in TIMCs associated with longer survival in metastatic tumors                                                                                                                                                                                    Bellmunt et al[@b52-ott-9-5023]
                                          410           Paraffin IHC; anti-PD-L1                                                                                                                             PD-L1 expression was detected on cell membrane and occasionally in cytoplasm                                                                        5%                                                      Tumor expression of PD-L1 was significantly associated with TIL expression of PD-1                                                                                                                                     PD-L1 expression was significantly associated with advanced tumor stage and a greater degree of TILs                                                                                                                                                                                                       PD-L1 expression independently predicted increased all-cause mortality after cystectomy for patients with organ-confined tumors                                                                                                                                            Boorjian et al[@b78-ott-9-5023]
                                          280           Paraffin IHC; anti-PD-L1 (clone 5H1)                                                                                                                 PD-L1 expressed on plasma membrane                                                                                                                  1%                                                      NA                                                                                                                                                                                                                     PD-L1 expression was associated with high-grade tumors and tumor infiltration by mononuclear cells                                                                                                                                                                                                         Increasing levels of PD-L1 expression correlate with increased local aggressiveness of this cancer                                                                                                                                                                         Inman et al[@b79-ott-9-5023]
                                          302           Paraffin IHC; anti-PD-L1                                                                                                                             PD-L1 expression primarily on the cell membrane; cytoplasmic staining was occasionally detected                                                     5%                                                      NA                                                                                                                                                                                                                     PD-L1 was not associated with various clinicopathological factors                                                                                                                                                                                                                                          In patients with organ-confined UCB, PD-L1 expression was associated with an increased risk of overall mortality                                                                                                                                                           Xylinas et al[@b80-ott-9-5023]
  Ovarian cancer                          70            Paraffin IHC; anti-PD-L1 (clone 27A2)                                                                                                                NA                                                                                                                                                  NA                                                      PD-L1 expression inversely correlated with intraepithelial CD8^+^ TIL count                                                                                                                                            PD-L1 had no statistically significant correlation with various clinicopathological factors                                                                                                                                                                                                                High expression of PD-L1 had worse 5-year survival rate and OS rate                                                                                                                                                                                                        Hamanishi et al[@b59-ott-9-5023]
                                          70            Paraffin IHC; anti-PD-L1 (27A2; MBL International Corporation)                                                                                       NA                                                                                                                                                  NA                                                      Negative correlation between CD8^+^ cell infiltration and PD-L1 tumor expression                                                                                                                                       NA                                                                                                                                                                                                                                                                                                         High PD-L1 expression had independent negative prognostic value                                                                                                                                                                                                            Hamanishi et al[@b67-ott-9-5023]
                                          NA            FACS, functional assays; anti-PD-L1 (BD Pharmingen Inc.) for FACS, 5H1 for functional assays                                                         PD-L1 present on nearly all myeloid DCs from tumor ascites and from tumor-draining lymph nodes                                                      NA                                                      NA                                                                                                                                                                                                                     NA                                                                                                                                                                                                                                                                                                         NA                                                                                                                                                                                                                                                                         Curiel et al[@b86-ott-9-5023]
  Breast cancer                           636           RNAscope assay                                                                                                                                       PD-L1 mRNA expressed in nearly 60% of breast tumor                                                                                                  NA                                                      Higher PD-L1 mRNA expression was significantly associated with increased TILs. The presence of elevated TILs was significantly associated with ER-negative status                                                      PD-L1 mRNA expression was significantly associated with the presence of elevated TILs but not other clinicopathological factors                                                                                                                                                                            PD-L1 mRNA expression was associated with longer recurrence-free survival                                                                                                                                                                                                  Schalper et al[@b60-ott-9-5023]
                                          44            FACS, frozen IHC; anti-PD-L1 (MIH1; eBioscience)                                                                                                     PD-L1 expressed both on membrane and in cytoplasm                                                                                                   NA                                                      NA                                                                                                                                                                                                                     Intratumoral PD-L1 expression was associated with histologic stage III-negative, estrogen receptor-negative, and progesterone receptor-negative patients. TIL PD-L1 was associated with large tumor size, histologic grade 3, positivity of Her2/neu status, and increased tumor lymphocyte infiltration   NA                                                                                                                                                                                                                                                                         Ghebeh et al[@b87-ott-9-5023]
  WT                                      191           Paraffin IHC; anti-PD-L1                                                                                                                             Eleven tumors expressed PD-L1. Tumors with AH were more likely to express PD-L1 compared to FH tumors                                               NA                                                      NA                                                                                                                                                                                                                     PD-L1 expression within WT correlates with biological aggressiveness, including stage and histology                                                                                                                                                                                                        Tumor PD-L1 expression was significantly predictive of cancer recurrence                                                                                                                                                                                                   Routh et al[@b88-ott-9-5023]
  Nasopharyngeal carcinoma                139           Paraffin IHC; anti-PD-L1                                                                                                                             PD-L1 expression was detected in 132 patients, which was located on tumor tissue                                                                    NA                                                      PD-1 and PD-L1 coexpression leading to T cell exhaustion                                                                                                                                                               PD-L1 expression had no significant correlation with clinicopathological factors such as age, tumor stage, lymph node metastasis, and clinical TNM staging                                                                                                                                                 High expression of PD-L1 in tumor tissue significantly correlated with a poor prognosis of DFS                                                                                                                                                                             Zhang et al[@b90-ott-9-5023]

**Abbreviations:** TIL, tumor-infiltrating lymphocyte; IHC, immunohistochemistry; NA, not available; WHO, World Health Organization; TIMCs, tumor-infiltrating mononuclear cells; FACS, fluorescence-activated cell sorting; DCs, dendritic cells; NSCLC, non-small-cell lung cancer; RFS, relapse-free survival; VPSI, visceral pleural surface invasion; OS, overall survival; TNM, tumor--node--metastasis; CRC, colorectal cancer; mAb, monoclonal antibody; MMR, mismatch repair; Tregs, regulatory T cells; DFS, disease-free survival; MEL, melanoma; ICC, intrahepatic cholangiocarcinoma; pTNM, pathological TNM; PCR, polymerase chain reaction; PE, phycoerythrin; HCC, hepatocellular carcinoma; RCC, renal cell carcinoma; UCB, urothelial cancer of the bladder; WT, Wilms' tumor; AH, anaplastic histology; FH, favorable histology.
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